Androgen deprivation therapy (ADT), a form of hormone therapy commonly used to treat prostate cancer, appears to confer protection against the virus that causes COVID-19, lowering the rate of infections and their severity, a new study suggests. The study, “Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study,” was published in the journal Annals of Oncology. COVID-19 is caused by the virus SARS-CoV-2. Recent research has shown this virus gets…
You must be logged in to read/download the full post.
The post ADT May Protect Prostate Cancer Patients from COVID-19, Study Suggests appeared first on BioNewsFeeds.